-
1
-
-
0034612175
-
Inflammation and Alzheimer’s disease
-
PID: 10858586, COI: 1:CAS:528:DC%2BD3cXktVSmt74%3D
-
Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O’Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer’s disease. Neurobiol Aging 21:383–421
-
(2000)
Neurobiol Aging
, vol.21
, pp. 383-421
-
-
Akiyama, H.1
Barger, S.2
Barnum, S.3
Bradt, B.4
Bauer, J.5
Cole, G.M.6
Cooper, N.R.7
Eikelenboom, P.8
Emmerling, M.9
Fiebich, B.L.10
Finch, C.E.11
Frautschy, S.12
Griffin, W.S.13
Hampel, H.14
Hull, M.15
Landreth, G.16
Lue, L.17
Mrak, R.18
Mackenzie, I.R.19
McGeer, P.L.20
O’Banion, M.K.21
Pachter, J.22
Pasinetti, G.23
Plata-Salaman, C.24
Rogers, J.25
Rydel, R.26
Shen, Y.27
Streit, W.28
Strohmeyer, R.29
Tooyoma, I.30
Van Muiswinkel, F.L.31
Veerhuis, R.32
Walker, D.33
Webster, S.34
Wegrzyniak, B.35
Wenk, G.36
Wyss-Coray, T.37
more..
-
2
-
-
0030805622
-
A generalised increase in protein carbonyls in the brain in Parkinson’s but not incidental Lewy body disease
-
PID: 9282961, COI: 1:CAS:528:DyaK2sXls1Chu70%3D
-
Alam ZI, Daniel SE, Lees AJ, Marsden DC, Jenner P, Halliwell B (1997a) A generalised increase in protein carbonyls in the brain in Parkinson’s but not incidental Lewy body disease. J Neurochem 69:1326–1329
-
(1997)
J Neurochem
, vol.69
, pp. 1326-1329
-
-
Alam, Z.I.1
Daniel, S.E.2
Lees, A.J.3
Marsden, D.C.4
Jenner, P.5
Halliwell, B.6
-
3
-
-
0030878073
-
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra
-
PID: 9282943, COI: 1:CAS:528:DyaK2sXls1Chtbs%3D
-
Alam ZI, Jenner A, Daniel SE, Lees AJ, Cairns N, Marsden CD, Jenner P, Halliwell B (1997b) Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 69:1196–1203
-
(1997)
J Neurochem
, vol.69
, pp. 1196-1203
-
-
Alam, Z.I.1
Jenner, A.2
Daniel, S.E.3
Lees, A.J.4
Cairns, N.5
Marsden, C.D.6
Jenner, P.7
Halliwell, B.8
-
4
-
-
0035344211
-
Experimental models of Parkinson’s disease
-
PID: 11331916, COI: 1:CAS:528:DC%2BD3MXjs1Ogtrs%3D
-
Beal MF (2001) Experimental models of Parkinson’s disease. Nat Rev Neurosci 2:325–334
-
(2001)
Nat Rev Neurosci
, vol.2
, pp. 325-334
-
-
Beal, M.F.1
-
5
-
-
0036570159
-
Oxidatively modified proteins in aging and disease
-
PID: 11978481, COI: 1:CAS:528:DC%2BD38XjtVeju7w%3D
-
Beal MF (2002) Oxidatively modified proteins in aging and disease. Free Radic Biol Med 32:797–803
-
(2002)
Free Radic Biol Med
, vol.32
, pp. 797-803
-
-
Beal, M.F.1
-
6
-
-
33846794822
-
The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology
-
PID: 17237347, COI: 1:CAS:528:DC%2BD2sXitVagsr4%3D
-
Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245–313
-
(2007)
Physiol Rev
, vol.87
, pp. 245-313
-
-
Bedard, K.1
Krause, K.H.2
-
7
-
-
35848966786
-
Protein aggregation mechanisms in synucleinopathies: commonalities and differences
-
PID: 17984679, COI: 1:CAS:528:DC%2BD2sXhtl2ntLzI
-
Beyer K, Ariza A (2007) Protein aggregation mechanisms in synucleinopathies: commonalities and differences. J Neuropathol Exp Neurol 66:965–974
-
(2007)
J Neuropathol Exp Neurol
, vol.66
, pp. 965-974
-
-
Beyer, K.1
Ariza, A.2
-
8
-
-
0027973242
-
Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
-
PID: 7526776, COI: 1:STN:280:DyaK2M%2FmvF2ntQ%3D%3D
-
Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, Hanley D, Trapp BD (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36:778–786
-
(1994)
Ann Neurol
, vol.36
, pp. 778-786
-
-
Bo, L.1
Dawson, T.M.2
Wesselingh, S.3
Mork, S.4
Choi, S.5
Kong, P.A.6
Hanley, D.7
Trapp, B.D.8
-
9
-
-
0035668684
-
Increased oxidative damage to DNA in a transgenic mouse model of Huntington’s disease
-
PID: 11752065, COI: 1:CAS:528:DC%2BD38XivFGjsw%3D%3D
-
Bogdanov MB, Andreassen OA, Dedeoglu A, Ferrante RJ, Beal MF (2001) Increased oxidative damage to DNA in a transgenic mouse model of Huntington’s disease. J Neurochem 79:1246–1249
-
(2001)
J Neurochem
, vol.79
, pp. 1246-1249
-
-
Bogdanov, M.B.1
Andreassen, O.A.2
Dedeoglu, A.3
Ferrante, R.J.4
Beal, M.F.5
-
10
-
-
0038233014
-
Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases
-
PID: 9166714, COI: 1:CAS:528:DyaK2sXjsVOgu7g%3D
-
Bolanos JP, Almeida A, Stewart V, Peuchen S, Land JM, Clark JB, Heales SJ (1997) Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem 68:2227–2240
-
(1997)
J Neurochem
, vol.68
, pp. 2227-2240
-
-
Bolanos, J.P.1
Almeida, A.2
Stewart, V.3
Peuchen, S.4
Land, J.M.5
Clark, J.B.6
Heales, S.J.7
-
11
-
-
26844505808
-
Toxin-induced models of Parkinson’s disease
-
PID: 16389312
-
Bove J, Prou D, Perier C, Przedborski S (2005) Toxin-induced models of Parkinson’s disease. NeuroRx 2:484–494
-
(2005)
NeuroRx
, vol.2
, pp. 484-494
-
-
Bove, J.1
Prou, D.2
Perier, C.3
Przedborski, S.4
-
12
-
-
0025863618
-
Neuropathological stageing of Alzheimer-related changes
-
PID: 1759558, COI: 1:STN:280:DyaK387gtFOiug%3D%3D
-
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259
-
(1991)
Acta Neuropathol
, vol.82
, pp. 239-259
-
-
Braak, H.1
Braak, E.2
-
13
-
-
84875697554
-
Glutathione peroxidases
-
PID: 23201771, COI: 1:CAS:528:DC%2BC3sXotFWn
-
Brigelius-Flohe R, Maiorino M (2013) Glutathione peroxidases. Biochim Biophys Acta 1830:3289–3303
-
(2013)
Biochim Biophys Acta
, vol.1830
, pp. 3289-3303
-
-
Brigelius-Flohe, R.1
Maiorino, M.2
-
14
-
-
33947675275
-
Oxidative damage in Huntington’s disease pathogenesis
-
PID: 17034350, COI: 1:CAS:528:DC%2BD28XhtVKntbzN
-
Browne SE, Beal MF (2006) Oxidative damage in Huntington’s disease pathogenesis. Antioxid Redox Signal 8:2061–2073
-
(2006)
Antioxid Redox Signal
, vol.8
, pp. 2061-2073
-
-
Browne, S.E.1
Beal, M.F.2
-
15
-
-
0030919567
-
Oxidative damage and metabolic dysfunction in Huntington’s disease: selective vulnerability of the basal ganglia
-
PID: 9153527, COI: 1:CAS:528:DyaK2sXjsF2qtLs%3D
-
Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, Bird ED, Beal MF (1997) Oxidative damage and metabolic dysfunction in Huntington’s disease: selective vulnerability of the basal ganglia. Ann Neurol 41:646–653
-
(1997)
Ann Neurol
, vol.41
, pp. 646-653
-
-
Browne, S.E.1
Bowling, A.C.2
MacGarvey, U.3
Baik, M.J.4
Berger, S.C.5
Muqit, M.M.6
Bird, E.D.7
Beal, M.F.8
-
16
-
-
0032903802
-
Oxidative stress in Huntington’s disease
-
PID: 9989457, COI: 1:CAS:528:DyaK1MXht1Cmsb0%3D
-
Browne SE, Ferrante RJ, Beal MF (1999) Oxidative stress in Huntington’s disease. Brain Pathol 9:147–163
-
(1999)
Brain Pathol
, vol.9
, pp. 147-163
-
-
Browne, S.E.1
Ferrante, R.J.2
Beal, M.F.3
-
17
-
-
84874111758
-
The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation
-
PID: 23219527, COI: 1:CAS:528:DC%2BC3sXotF2h
-
Bryan HK, Olayanju A, Goldring CE, Park BK (2013) The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. Biochem Pharmacol 85:705–717
-
(2013)
Biochem Pharmacol
, vol.85
, pp. 705-717
-
-
Bryan, H.K.1
Olayanju, A.2
Goldring, C.E.3
Park, B.K.4
-
18
-
-
0037386086
-
The metallobiology of Alzheimer’s disease
-
PID: 12689772, COI: 1:CAS:528:DC%2BD3sXis12nsb8%3D
-
Bush AI (2003) The metallobiology of Alzheimer’s disease. Trends Neurosci 26:207–214
-
(2003)
Trends Neurosci
, vol.26
, pp. 207-214
-
-
Bush, A.I.1
-
19
-
-
0028934696
-
Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis
-
PID: 7607784, COI: 1:STN:280:DyaK2MzjtF2isw%3D%3D
-
Calabrese V, Raffaele R, Cosentino E, Rizza V (1994) Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis. Int J Clin Pharmacol Res 14:119–123
-
(1994)
Int J Clin Pharmacol Res
, vol.14
, pp. 119-123
-
-
Calabrese, V.1
Raffaele, R.2
Cosentino, E.3
Rizza, V.4
-
20
-
-
11844253848
-
Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription
-
PID: 15611470, COI: 1:CAS:528:DC%2BD2MXmtlelsA%3D%3D
-
Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, Johnson JA (2005) Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc Natl Acad Sci USA 102:244–249
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 244-249
-
-
Calkins, M.J.1
Jakel, R.J.2
Johnson, D.A.3
Chan, K.4
Kan, Y.W.5
Johnson, J.A.6
-
21
-
-
79953291261
-
Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis
-
PID: 21446022, COI: 1:CAS:528:DC%2BC3MXls1Omtbk%3D
-
Campbell GR, Ziabreva I, Reeve AK, Krishnan KJ, Reynolds R, Howell O, Lassmann H, Turnbull DM, Mahad DJ (2011) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 69:481–492
-
(2011)
Ann Neurol
, vol.69
, pp. 481-492
-
-
Campbell, G.R.1
Ziabreva, I.2
Reeve, A.K.3
Krishnan, K.J.4
Reynolds, R.5
Howell, O.6
Lassmann, H.7
Turnbull, D.M.8
Mahad, D.J.9
-
22
-
-
33744819999
-
Antioxidants in multiple sclerosis: do they have a role in therapy?
-
PID: 16734496, COI: 1:CAS:528:DC%2BD28XnvVyktb4%3D
-
Carlson NG, Rose JW (2006) Antioxidants in multiple sclerosis: do they have a role in therapy? CNS Drugs 20:433–441
-
(2006)
CNS Drugs
, vol.20
, pp. 433-441
-
-
Carlson, N.G.1
Rose, J.W.2
-
23
-
-
34249930833
-
Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington’s disease patients
-
PID: 17543886, COI: 1:CAS:528:DC%2BD2sXmtlaiu7s%3D
-
Chen CM, Wu YR, Cheng ML, Liu JL, Lee YM, Lee PW, Soong BW, Chiu DT (2007) Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington’s disease patients. Biochem Biophys Res Commun 359:335–340
-
(2007)
Biochem Biophys Res Commun
, vol.359
, pp. 335-340
-
-
Chen, C.M.1
Wu, Y.R.2
Cheng, M.L.3
Liu, J.L.4
Lee, Y.M.5
Lee, P.W.6
Soong, B.W.7
Chiu, D.T.8
-
24
-
-
41849109453
-
Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis
-
PID: 18234693
-
Chen JW, Breckwoldt MO, Aikawa E, Chiang G, Weissleder R (2008) Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis. Brain 131:1123–1133
-
(2008)
Brain
, vol.131
, pp. 1123-1133
-
-
Chen, J.W.1
Breckwoldt, M.O.2
Aikawa, E.3
Chiang, G.4
Weissleder, R.5
-
25
-
-
62449132771
-
Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson’s disease: critical role for the astrocyte
-
PID: 19196989, COI: 1:CAS:528:DC%2BD1MXislSkurg%3D
-
Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA (2009) Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson’s disease: critical role for the astrocyte. Proc Natl Acad Sci USA 106:2933–2938
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 2933-2938
-
-
Chen, P.C.1
Vargas, M.R.2
Pani, A.K.3
Smeyne, R.J.4
Johnson, D.A.5
Kan, Y.W.6
Johnson, J.A.7
-
26
-
-
49349106093
-
Redox imbalance in Parkinson’s disease
-
PID: 18358848, COI: 1:CAS:528:DC%2BD1cXhtVartr7O
-
Chinta SJ, Andersen JK (2008) Redox imbalance in Parkinson’s disease. Biochim Biophys Acta 1780:1362–1367
-
(2008)
Biochim Biophys Acta
, vol.1780
, pp. 1362-1367
-
-
Chinta, S.J.1
Andersen, J.K.2
-
27
-
-
33750052885
-
DJ-1, a cancer- and Parkinson’s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2
-
PID: 17015834, COI: 1:CAS:528:DC%2BD28XhtFais7vN
-
Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP (2006) DJ-1, a cancer- and Parkinson’s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA 103:15091–15096
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 15091-15096
-
-
Clements, C.M.1
McNally, R.S.2
Conti, B.J.3
Mak, T.W.4
Ting, J.P.5
-
28
-
-
0023642584
-
Production of superoxide anions by a CNS macrophage, the microglia
-
PID: 2822487, COI: 1:CAS:528:DyaL1cXksFGl
-
Colton CA, Gilbert DL (1987) Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 223:284–288
-
(1987)
FEBS Lett
, vol.223
, pp. 284-288
-
-
Colton, C.A.1
Gilbert, D.L.2
-
29
-
-
0034039478
-
Microglial contribution to oxidative stress in Alzheimer’s disease
-
PID: 10863548, COI: 1:CAS:528:DC%2BD3cXks1ShsLY%3D
-
Colton CA, Chernyshev ON, Gilbert DL, Vitek MP (2000) Microglial contribution to oxidative stress in Alzheimer’s disease. Ann N Y Acad Sci 899:292–307
-
(2000)
Ann N Y Acad Sci
, vol.899
, pp. 292-307
-
-
Colton, C.A.1
Chernyshev, O.N.2
Gilbert, D.L.3
Vitek, M.P.4
-
30
-
-
79959776301
-
NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson’s disease
-
PID: 21747966, COI: 1:CAS:528:DC%2BC3MXptFynu7g%3D
-
Cook AL, Vitale AM, Ravishankar S, Matigian N, Sutherland GT, Shan J, Sutharsan R, Perry C, Silburn PA, Mellick GD, Whitelaw ML, Wells CA, kay-Sim A, Wood SA (2011) NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson’s disease. PLoS one 6:e21907
-
(2011)
PLoS one
, vol.6
, pp. e21907
-
-
Cook, A.L.1
Vitale, A.M.2
Ravishankar, S.3
Matigian, N.4
Sutherland, G.T.5
Shan, J.6
Sutharsan, R.7
Perry, C.8
Silburn, P.A.9
Mellick, G.D.10
Whitelaw, M.L.11
Wells, C.A.12
kay-Sim, A.13
Wood, S.A.14
-
31
-
-
0141752795
-
Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival
-
PID: 14517290, COI: 1:CAS:528:DC%2BD3sXotVSrur0%3D
-
Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA (2003) Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol 23:7198–7209
-
(2003)
Mol Cell Biol
, vol.23
, pp. 7198-7209
-
-
Cullinan, S.B.1
Zhang, D.2
Hannink, M.3
Arvisais, E.4
Kaufman, R.J.5
Diehl, J.A.6
-
32
-
-
3042857903
-
Alzheimer’s disease
-
PID: 15229308, COI: 1:CAS:528:DC%2BD2cXltlOjsb8%3D
-
Cummings JL (2004) Alzheimer’s disease. N Engl J Med 351:56–67
-
(2004)
N Engl J Med
, vol.351
, pp. 56-67
-
-
Cummings, J.L.1
-
33
-
-
0242363670
-
Molecular pathways of neurodegeneration in Parkinson’s disease
-
PID: 14593166, COI: 1:CAS:528:DC%2BD3sXos1Cmt7w%3D
-
Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson’s disease. Science 302:819–822
-
(2003)
Science
, vol.302
, pp. 819-822
-
-
Dawson, T.M.1
Dawson, V.L.2
-
34
-
-
0030636128
-
Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions
-
PID: 8990125
-
De Groot CJ, Ruuls SR, Theeuwes JW, Dijkstra CD, Van der Valk P (1997) Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 56:10–20
-
(1997)
J Neuropathol Exp Neurol
, vol.56
, pp. 10-20
-
-
De Groot, C.J.1
Ruuls, S.R.2
Theeuwes, J.W.3
Dijkstra, C.D.4
Van der Valk, P.5
-
35
-
-
0024585155
-
Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease
-
PID: 2911023, COI: 1:CAS:528:DyaL1MXhtFalsrc%3D
-
Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease. J Neurochem 52:381–389
-
(1989)
J Neurochem
, vol.52
, pp. 381-389
-
-
Dexter, D.T.1
Carter, C.J.2
Wells, F.R.3
Javoy-Agid, F.4
Agid, Y.5
Lees, A.6
Jenner, P.7
Marsden, C.D.8
-
36
-
-
33745096512
-
Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer’s disease
-
PID: 16770743, COI: 1:CAS:528:DC%2BD28XlsFCjt7Y%3D
-
Ding Q, Markesbery WR, Cecarini V, Keller JN (2006) Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer’s disease. Neurochem Res 31:705–710
-
(2006)
Neurochem Res
, vol.31
, pp. 705-710
-
-
Ding, Q.1
Markesbery, W.R.2
Cecarini, V.3
Keller, J.N.4
-
37
-
-
2942729775
-
Metals in our minds: therapeutic implications for neurodegenerative disorders
-
PID: 15207800, COI: 1:CAS:528:DC%2BD2cXmtVOmt7w%3D
-
Doraiswamy PM, Finefrock AE (2004) Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol 3:431–434
-
(2004)
Lancet Neurol
, vol.3
, pp. 431-434
-
-
Doraiswamy, P.M.1
Finefrock, A.E.2
-
38
-
-
43049175139
-
Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson’s disease
-
PID: 18342017, COI: 1:CAS:528:DC%2BD1cXlslOru7o%3D
-
Drechsel DA, Patel M (2008) Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson’s disease. Free Radic Biol Med 44:1873–1886
-
(2008)
Free Radic Biol Med
, vol.44
, pp. 1873-1886
-
-
Drechsel, D.A.1
Patel, M.2
-
39
-
-
12244291916
-
Peroxide detoxification by brain cells
-
PID: 15573410, COI: 1:CAS:528:DC%2BD2MXltlCltg%3D%3D
-
Dringen R, Pawlowski PG, Hirrlinger J (2005) Peroxide detoxification by brain cells. J Neurosci Res 79:157–165
-
(2005)
J Neurosci Res
, vol.79
, pp. 157-165
-
-
Dringen, R.1
Pawlowski, P.G.2
Hirrlinger, J.3
-
40
-
-
0642375798
-
Mitochondrial dysfunction, apoptotic cell death, and Alzheimer’s disease
-
PID: 14555243, COI: 1:CAS:528:DC%2BD3sXnvVeqsLg%3D
-
Eckert A, Keil U, Marques CA, Bonert A, Frey C, Schussel K, Muller WE (2003) Mitochondrial dysfunction, apoptotic cell death, and Alzheimer’s disease. Biochem Pharmacol 66:1627–1634
-
(2003)
Biochem Pharmacol
, vol.66
, pp. 1627-1634
-
-
Eckert, A.1
Keil, U.2
Marques, C.A.3
Bonert, A.4
Frey, C.5
Schussel, K.6
Muller, W.E.7
-
41
-
-
79551626268
-
Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington’s disease
-
PID: 21297955, COI: 1:CAS:528:DC%2BC3MXhvVKkurc%3D
-
Ellrichmann G, Petrasch-Parwez E, Lee DH, Reick C, Arning L, Saft C, Gold R, Linker RA (2011) Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington’s disease. PLoS one 6:e16172
-
(2011)
PLoS one
, vol.6
, pp. e16172
-
-
Ellrichmann, G.1
Petrasch-Parwez, E.2
Lee, D.H.3
Reick, C.4
Arning, L.5
Saft, C.6
Gold, R.7
Linker, R.A.8
-
42
-
-
0025814980
-
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
-
PID: 1937131, COI: 1:CAS:528:DyaK3MXmsFSnsbo%3D
-
Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81–128
-
(1991)
Free Radic Biol Med
, vol.11
, pp. 81-128
-
-
Esterbauer, H.1
Schaur, R.J.2
Zollner, H.3
-
43
-
-
4444339833
-
Oxidative DNA damage and disease: induction, repair and significance
-
PID: 15341901, COI: 1:CAS:528:DC%2BD2cXntlelsrc%3D
-
Evans MD, Dizdaroglu M, Cooke MS (2004) Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 567:1–61
-
(2004)
Mutat Res
, vol.567
, pp. 1-61
-
-
Evans, M.D.1
Dizdaroglu, M.2
Cooke, M.S.3
-
44
-
-
84891589937
-
Antisense oligonucleotide against GSK-3beta in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: involvement of transcription factor Nrf2 and implications for Alzheimer disease
-
PID: 24355211, COI: 1:CAS:528:DC%2BC2cXitlehu78%3D
-
Farr SA, Ripley JL, Sultana R, Zhang Z, Niehoff ML, Platt TL, Murphy MP, Morley JE, Kumar V, Butterfield DA (2014) Antisense oligonucleotide against GSK-3beta in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: involvement of transcription factor Nrf2 and implications for Alzheimer disease. Free Radic Biol Med 67:387–395
-
(2014)
Free Radic Biol Med
, vol.67
, pp. 387-395
-
-
Farr, S.A.1
Ripley, J.L.2
Sultana, R.3
Zhang, Z.4
Niehoff, M.L.5
Platt, T.L.6
Murphy, M.P.7
Morley, J.E.8
Kumar, V.9
Butterfield, D.A.10
-
45
-
-
0036523110
-
Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington’s disease
-
PID: 11880489, COI: 1:CAS:528:DC%2BD38XhvValsbc%3D
-
Ferrante RJ, Andreassen OA, Dedeoglu A, Ferrante KL, Jenkins BG, Hersch SM, Beal MF (2002) Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington’s disease. J Neurosci 22:1592–1599
-
(2002)
J Neurosci
, vol.22
, pp. 1592-1599
-
-
Ferrante, R.J.1
Andreassen, O.A.2
Dedeoglu, A.3
Ferrante, K.L.4
Jenkins, B.G.5
Hersch, S.M.6
Beal, M.F.7
-
46
-
-
28044438183
-
Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity
-
PID: 16320727, COI: 1:CAS:528:DC%2BD28XotFY%3D
-
Ferretti G, Bacchetti T, Principi F, Di Ludovico F, Viti B, Angeleri VA, Danni M, Provinciali L (2005) Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity. Mult Scler 11:677–682
-
(2005)
Mult Scler
, vol.11
, pp. 677-682
-
-
Ferretti, G.1
Bacchetti, T.2
Principi, F.3
Di Ludovico, F.4
Viti, B.5
Angeleri, V.A.6
Danni, M.7
Provinciali, L.8
-
47
-
-
84884132096
-
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse
-
PID: 23871488, COI: 1:CAS:528:DC%2BC3sXhtFCht7vM
-
Fiebiger SM, Bros H, Grobosch T, Janssen A, Chanvillard C, Paul F, Dorr J, Millward JM, Infante-Duarte C (2013) The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse. J Neuroimmunol 262:66–71
-
(2013)
J Neuroimmunol
, vol.262
, pp. 66-71
-
-
Fiebiger, S.M.1
Bros, H.2
Grobosch, T.3
Janssen, A.4
Chanvillard, C.5
Paul, F.6
Dorr, J.7
Millward, J.M.8
Infante-Duarte, C.9
-
48
-
-
84857538385
-
NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury
-
PID: 22366799
-
Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Drexhage J, Mahad D, Bradl M, van Horssen J, Lassmann H (2012) NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 135:886–899
-
(2012)
Brain
, vol.135
, pp. 886-899
-
-
Fischer, M.T.1
Sharma, R.2
Lim, J.L.3
Haider, L.4
Frischer, J.M.5
Drexhage, J.6
Mahad, D.7
Bradl, M.8
van Horssen, J.9
Lassmann, H.10
-
49
-
-
84866355653
-
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis
-
PID: 22992072, COI: 1:CAS:528:DC%2BC38XhsVKkur3E
-
Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT (2012) Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med 367:1087–1097
-
(2012)
N Engl J Med
, vol.367
, pp. 1087-1097
-
-
Fox, R.J.1
Miller, D.H.2
Phillips, J.T.3
Hutchinson, M.4
Havrdova, E.5
Kita, M.6
Yang, M.7
Raghupathi, K.8
Novas, M.9
Sweetser, M.T.10
Viglietta, V.11
Dawson, K.T.12
-
50
-
-
70449470636
-
Oxidative stress disrupts oligodendrocyte maturation
-
PID: 19479983, COI: 1:CAS:528:DC%2BD1MXhtFagtbfK
-
French HM, Reid M, Mamontov P, Simmons RA, Grinspan JB (2009) Oxidative stress disrupts oligodendrocyte maturation. J Neurosci Res 87:3076–3087
-
(2009)
J Neurosci Res
, vol.87
, pp. 3076-3087
-
-
French, H.M.1
Reid, M.2
Mamontov, P.3
Simmons, R.A.4
Grinspan, J.B.5
-
51
-
-
0034986361
-
Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier
-
PID: 11406187, COI: 1:CAS:528:DC%2BD3MXkt1Kis70%3D
-
Gilgun-Sherki Y, Melamed E, Offen D (2001) Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40:959–975
-
(2001)
Neuropharmacology
, vol.40
, pp. 959-975
-
-
Gilgun-Sherki, Y.1
Melamed, E.2
Offen, D.3
-
52
-
-
84866423965
-
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
-
PID: 22992073, COI: 1:CAS:528:DC%2BC38XhsVKkur3F
-
Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT (2012) Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 367:1098–1107
-
(2012)
N Engl J Med
, vol.367
, pp. 1098-1107
-
-
Gold, R.1
Kappos, L.2
Arnold, D.L.3
Bar-Or, A.4
Giovannoni, G.5
Selmaj, K.6
Tornatore, C.7
Sweetser, M.T.8
Yang, M.9
Sheikh, S.I.10
Dawson, K.T.11
-
53
-
-
32644481227
-
Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction
-
PID: 16472774, COI: 1:CAS:528:DC%2BD28Xhs1Wmur0%3D
-
Goswami A, Dikshit P, Mishra A, Mulherkar S, Nukina N, Jana NR (2006) Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction. Biochem Biophys Res Commun 342:184–190
-
(2006)
Biochem Biophys Res Commun
, vol.342
, pp. 184-190
-
-
Goswami, A.1
Dikshit, P.2
Mishra, A.3
Mulherkar, S.4
Nukina, N.5
Jana, N.R.6
-
54
-
-
38349125335
-
Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis
-
PID: 18042261
-
Gray E, Thomas TL, Betmouni S, Scolding N, Love S (2008a) Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol 18:86–95
-
(2008)
Brain Pathol
, vol.18
, pp. 86-95
-
-
Gray, E.1
Thomas, T.L.2
Betmouni, S.3
Scolding, N.4
Love, S.5
-
55
-
-
51349137371
-
Elevated myeloperoxidase activity in white matter in multiple sclerosis
-
PID: 18723077, COI: 1:CAS:528:DC%2BD1cXhtFWls7fF
-
Gray E, Thomas TL, Betmouni S, Scolding N, Love S (2008b) Elevated myeloperoxidase activity in white matter in multiple sclerosis. Neurosci Lett 444:195–198
-
(2008)
Neurosci Lett
, vol.444
, pp. 195-198
-
-
Gray, E.1
Thomas, T.L.2
Betmouni, S.3
Scolding, N.4
Love, S.5
-
56
-
-
0033544327
-
Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis
-
PID: 10563647, COI: 1:CAS:528:DyaK1MXnvVKns7s%3D
-
Greco A, Minghetti L, Sette G, Fieschi C, Levi G (1999) Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis. Neurology 53:1876–1879
-
(1999)
Neurology
, vol.53
, pp. 1876-1879
-
-
Greco, A.1
Minghetti, L.2
Sette, G.3
Fieschi, C.4
Levi, G.5
-
57
-
-
79959723400
-
Oxidative damage in multiple sclerosis lesions
-
PID: 21653539
-
Haider L, Fischer MT, Frischer JM, Bauer J, Hoftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H (2011) Oxidative damage in multiple sclerosis lesions. Brain 134:1914–1924
-
(2011)
Brain
, vol.134
, pp. 1914-1924
-
-
Haider, L.1
Fischer, M.T.2
Frischer, J.M.3
Bauer, J.4
Hoftberger, R.5
Botond, G.6
Esterbauer, H.7
Binder, C.J.8
Witztum, J.L.9
Lassmann, H.10
-
58
-
-
0347755530
-
DJ-1 mutations in Parkinson’s disease
-
PID: 14707326, COI: 1:STN:280:DC%2BD2c%2FjvVSnsw%3D%3D
-
Healy DG, bou-Sleiman PM, Valente EM, Gilks WP, Bhatia K, Quinn N, Lees AJ, Wood NW (2004a) DJ-1 mutations in Parkinson’s disease. J Neurol Neurosurg Psychiatry 75:144–145
-
(2004)
J Neurol Neurosurg Psychiatry
, vol.75
, pp. 144-145
-
-
Healy, D.G.1
bou-Sleiman, P.M.2
Valente, E.M.3
Gilks, W.P.4
Bhatia, K.5
Quinn, N.6
Lees, A.J.7
Wood, N.W.8
-
59
-
-
5644228612
-
PINK, PANK, or PARK? A clinicians’ guide to familial parkinsonism
-
PID: 15488458, COI: 1:CAS:528:DC%2BD2cXhtVaks7jM
-
Healy DG, bou-Sleiman PM, Wood NW (2004b) PINK, PANK, or PARK? A clinicians’ guide to familial parkinsonism. Lancet Neurol 3:652–662
-
(2004)
Lancet Neurol
, vol.3
, pp. 652-662
-
-
Healy, D.G.1
bou-Sleiman, P.M.2
Wood, N.W.3
-
60
-
-
11844264954
-
Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis
-
PID: 15611292, COI: 1:CAS:528:DC%2BD2cXhtFGmurbE
-
Hendriks JJ, Alblas J, Van Der Pol SM, van Tol EA, Dijkstra CD, De Vries HE (2004) Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J Exp Med 200:1667–1672
-
(2004)
J Exp Med
, vol.200
, pp. 1667-1672
-
-
Hendriks, J.J.1
Alblas, J.2
Van Der Pol, S.M.3
van Tol, E.A.4
Dijkstra, C.D.5
De Vries, H.E.6
-
61
-
-
33644927838
-
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG
-
PID: 16434666, COI: 1:CAS:528:DC%2BD28XpsFGj
-
Hersch SM, Gevorkian S, Marder K, Moskowitz C, Feigin A, Cox M, Como P, Zimmerman C, Lin M, Zhang L, Ulug AM, Beal MF, Matson W, Bogdanov M, Ebbel E, Zaleta A, Kaneko Y, Jenkins B, Hevelone N, Zhang H, Yu H, Schoenfeld D, Ferrante R, Rosas HD (2006) Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG. Neurology 66:250–252
-
(2006)
Neurology
, vol.66
, pp. 250-252
-
-
Hersch, S.M.1
Gevorkian, S.2
Marder, K.3
Moskowitz, C.4
Feigin, A.5
Cox, M.6
Como, P.7
Zimmerman, C.8
Lin, M.9
Zhang, L.10
Ulug, A.M.11
Beal, M.F.12
Matson, W.13
Bogdanov, M.14
Ebbel, E.15
Zaleta, A.16
Kaneko, Y.17
Jenkins, B.18
Hevelone, N.19
Zhang, H.20
Yu, H.21
Schoenfeld, D.22
Ferrante, R.23
Rosas, H.D.24
more..
-
62
-
-
77956207696
-
Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury
-
PID: 20463398
-
Higgins GC, Beart PM, Shin YS, Chen MJ, Cheung NS, Nagley P (2010) Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. J Alzheimers Dis 20(Suppl 2):S453–S473
-
(2010)
J Alzheimers Dis
, vol.20
, pp. S453-S473
-
-
Higgins, G.C.1
Beart, P.M.2
Shin, Y.S.3
Chen, M.J.4
Cheung, N.S.5
Nagley, P.6
-
63
-
-
0036249816
-
Peroxiredoxins
-
PID: 12033427, COI: 1:CAS:528:DC%2BD38XksVajtro%3D
-
Hofmann B, Hecht HJ, Flohe L (2002) Peroxiredoxins. Biol Chem 383:347–364
-
(2002)
Biol Chem
, vol.383
, pp. 347-364
-
-
Hofmann, B.1
Hecht, H.J.2
Flohe, L.3
-
64
-
-
65349093893
-
The unfolded protein response is activated in pretangle neurons in Alzheimer’s disease hippocampus
-
PID: 19264902, COI: 1:CAS:528:DC%2BD1MXksVOkt74%3D
-
Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Eikelenboom P, Scheper W (2009) The unfolded protein response is activated in pretangle neurons in Alzheimer’s disease hippocampus. Am J Pathol 174:1241–1251
-
(2009)
Am J Pathol
, vol.174
, pp. 1241-1251
-
-
Hoozemans, J.J.1
van Haastert, E.S.2
Nijholt, D.A.3
Rozemuller, A.J.4
Eikelenboom, P.5
Scheper, W.6
-
65
-
-
1842504323
-
Redox-active metals, oxidative stress, and Alzheimer’s disease pathology
-
PID: 15105262, COI: 1:CAS:528:DC%2BD2cXjvVOmsrw%3D
-
Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT (2004) Redox-active metals, oxidative stress, and Alzheimer’s disease pathology. Ann N Y Acad Sci 1012:153–163
-
(2004)
Ann N Y Acad Sci
, vol.1012
, pp. 153-163
-
-
Huang, X.1
Moir, R.D.2
Tanzi, R.E.3
Bush, A.I.4
Rogers, J.T.5
-
66
-
-
0028889831
-
Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species
-
PID: 8581507, COI: 1:CAS:528:DyaK2MXptVehtrk%3D
-
Husain J, Juurlink BH (1995) Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species. Brain Res 698:86–94
-
(1995)
Brain Res
, vol.698
, pp. 86-94
-
-
Husain, J.1
Juurlink, B.H.2
-
67
-
-
0034717329
-
Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages
-
PID: 10821856, COI: 1:CAS:528:DC%2BD3cXjvFaisbc%3D
-
Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M (2000) Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275:16023–16029
-
(2000)
J Biol Chem
, vol.275
, pp. 16023-16029
-
-
Ishii, T.1
Itoh, K.2
Takahashi, S.3
Sato, H.4
Yanagawa, T.5
Katoh, Y.6
Bannai, S.7
Yamamoto, M.8
-
68
-
-
33750088991
-
NQO1 and NQO2 regulation of humoral immunity and autoimmunity
-
PID: 16905546, COI: 1:CAS:528:DC%2BD28XhtVCrsLnL
-
Iskander K, Li J, Han S, Zheng B, Jaiswal AK (2006) NQO1 and NQO2 regulation of humoral immunity and autoimmunity. J Biol Chem 281:30917–30924
-
(2006)
J Biol Chem
, vol.281
, pp. 30917-30924
-
-
Iskander, K.1
Li, J.2
Han, S.3
Zheng, B.4
Jaiswal, A.K.5
-
69
-
-
72649092390
-
Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson’s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process
-
PID: 19944739, COI: 1:CAS:528:DC%2BC3cXotFen
-
Isobe C, Abe T, Terayama Y (2010) Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson’s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. Neurosci Lett 469:159–163
-
(2010)
Neurosci Lett
, vol.469
, pp. 159-163
-
-
Isobe, C.1
Abe, T.2
Terayama, Y.3
-
70
-
-
12444257799
-
Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles
-
PID: 12653965, COI: 1:CAS:528:DC%2BD3sXivFOjuro%3D
-
Itoh K, Wakabayashi N, Katoh Y, Ishii T, O’Connor T, Yamamoto M (2003) Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 8:379–391
-
(2003)
Genes Cells
, vol.8
, pp. 379-391
-
-
Itoh, K.1
Wakabayashi, N.2
Katoh, Y.3
Ishii, T.4
O’Connor, T.5
Yamamoto, M.6
-
71
-
-
0033800922
-
Regulation of genes encoding NAD(P)H:quinone oxidoreductases
-
PID: 11035254, COI: 1:CAS:528:DC%2BD3cXnslWmtrY%3D
-
Jaiswal AK (2000) Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Radic Biol Med 29:254–262
-
(2000)
Free Radic Biol Med
, vol.29
, pp. 254-262
-
-
Jaiswal, A.K.1
-
72
-
-
24044447603
-
Induction of the protective antioxidant response element pathway by 6-hydroxydopamine in vivo and in vitro
-
PID: 15976186, COI: 1:CAS:528:DC%2BD2MXovVOjsbs%3D
-
Jakel RJ, Kern JT, Johnson DA, Johnson JA (2005) Induction of the protective antioxidant response element pathway by 6-hydroxydopamine in vivo and in vitro. Toxicol Sci 87:176–186
-
(2005)
Toxicol Sci
, vol.87
, pp. 176-186
-
-
Jakel, R.J.1
Kern, J.T.2
Johnson, D.A.3
Johnson, J.A.4
-
73
-
-
33947307990
-
Nrf2-mediated protection against 6-hydroxydopamine
-
PID: 17336276, COI: 1:CAS:528:DC%2BD2sXjsVWhtbs%3D
-
Jakel RJ, Townsend JA, Kraft AD, Johnson JA (2007) Nrf2-mediated protection against 6-hydroxydopamine. Brain Res 1144:192–201
-
(2007)
Brain Res
, vol.1144
, pp. 192-201
-
-
Jakel, R.J.1
Townsend, J.A.2
Kraft, A.D.3
Johnson, J.A.4
-
74
-
-
41149163183
-
Parkinson’s disease: clinical features and diagnosis
-
PID: 18344392, COI: 1:STN:280:DC%2BD1c7oslamtA%3D%3D
-
Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368–376
-
(2008)
J Neurol Neurosurg Psychiatry
, vol.79
, pp. 368-376
-
-
Jankovic, J.1
-
75
-
-
40449127705
-
Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia
-
PID: 18322367, COI: 1:CAS:528:DC%2BD1cXjs1Whtrs%3D
-
Jellinger KA (2008) Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener Dis 5:118–121
-
(2008)
Neurodegener Dis
, vol.5
, pp. 118-121
-
-
Jellinger, K.A.1
-
76
-
-
84897093101
-
Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52
-
PID: 24667209
-
Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GV (2014) Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nat Commun 5:3496
-
(2014)
Nat Commun
, vol.5
, pp. 3496
-
-
Jo, C.1
Gundemir, S.2
Pritchard, S.3
Jin, Y.N.4
Rahman, I.5
Johnson, G.V.6
-
77
-
-
24044471309
-
Superoxide dismutases and their impact upon human health
-
COI: 1:CAS:528:DC%2BD2MXpslygtbc%3D
-
Johnson F, Giulivi C (2005) Superoxide dismutases and their impact upon human health. Mol Asp Med 26:340–352
-
(2005)
Mol Asp Med
, vol.26
, pp. 340-352
-
-
Johnson, F.1
Giulivi, C.2
-
78
-
-
77951557888
-
The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis
-
PID: 19910389, COI: 1:CAS:528:DC%2BC3cXjsleisbg%3D
-
Johnson DA, Amirahmadi S, Ward C, Fabry Z, Johnson JA (2010) The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol Sci 114:237–246
-
(2010)
Toxicol Sci
, vol.114
, pp. 237-246
-
-
Johnson, D.A.1
Amirahmadi, S.2
Ward, C.3
Fabry, Z.4
Johnson, J.A.5
-
79
-
-
0032054439
-
Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress
-
PID: 9517569, COI: 1:STN:280:DyaK1c7ns1OntA%3D%3D
-
Juurlink BH, Thorburne SK, Hertz L (1998) Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. Glia 22:371–378
-
(1998)
Glia
, vol.22
, pp. 371-378
-
-
Juurlink, B.H.1
Thorburne, S.K.2
Hertz, L.3
-
80
-
-
53749088028
-
Nuclear factor erythroid 2-related factor 2 protects against beta amyloid
-
PID: 18706502, COI: 1:CAS:528:DC%2BD1cXht1Klt7jE
-
Kanninen K, Malm TM, Jyrkkanen HK, Goldsteins G, Keksa-Goldsteine V, Tanila H, Yamamoto M, Yla-Herttuala S, Levonen AL, Koistinaho J (2008) Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Mol Cell Neurosci 39:302–313
-
(2008)
Mol Cell Neurosci
, vol.39
, pp. 302-313
-
-
Kanninen, K.1
Malm, T.M.2
Jyrkkanen, H.K.3
Goldsteins, G.4
Keksa-Goldsteine, V.5
Tanila, H.6
Yamamoto, M.7
Yla-Herttuala, S.8
Levonen, A.L.9
Koistinaho, J.10
-
81
-
-
70349482547
-
Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer’s disease
-
PID: 19805328, COI: 1:CAS:528:DC%2BD1MXht1Kqtb7N
-
Kanninen K, Heikkinen R, Malm T, Rolova T, Kuhmonen S, Leinonen H, Yla-Herttuala S, Tanila H, Levonen AL, Koistinaho M, Koistinaho J (2009) Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA 106:16505–16510
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 16505-16510
-
-
Kanninen, K.1
Heikkinen, R.2
Malm, T.3
Rolova, T.4
Kuhmonen, S.5
Leinonen, H.6
Yla-Herttuala, S.7
Tanila, H.8
Levonen, A.L.9
Koistinaho, M.10
Koistinaho, J.11
-
82
-
-
0032767565
-
Nonenzymatic antioxidants of blood in multiple sclerosis
-
PID: 10463352, COI: 1:STN:280:DyaK1MzptV2qsQ%3D%3D
-
Karg E, Klivenyi P, Nemeth I, Bencsik K, Pinter S, Vecsei L (1999) Nonenzymatic antioxidants of blood in multiple sclerosis. J Neurol 246:533–539
-
(1999)
J Neurol
, vol.246
, pp. 533-539
-
-
Karg, E.1
Klivenyi, P.2
Nemeth, I.3
Bencsik, K.4
Pinter, S.5
Vecsei, L.6
-
83
-
-
84902578456
-
Nrf2 regulates neurogenesis and protects neural progenitor cells against Abeta toxicity
-
PID: 24753106, COI: 1:CAS:528:DC%2BC2cXhsVSqsrvF
-
Karkkainen V, Pomeshchik Y, Savchenko E, Dhungana H, Kurronen A, Lehtonen S, Naumenko N, Tavi P, Levonen AL, Yamamoto M, Malm T, Magga J, Kanninen KM, Koistinaho J (2014) Nrf2 regulates neurogenesis and protects neural progenitor cells against Abeta toxicity. Stem Cells 32:1904–1916
-
(2014)
Stem Cells
, vol.32
, pp. 1904-1916
-
-
Karkkainen, V.1
Pomeshchik, Y.2
Savchenko, E.3
Dhungana, H.4
Kurronen, A.5
Lehtonen, S.6
Naumenko, N.7
Tavi, P.8
Levonen, A.L.9
Yamamoto, M.10
Malm, T.11
Magga, J.12
Kanninen, K.M.13
Koistinaho, J.14
-
84
-
-
0037101878
-
Chemistry-based studies on oxidative DNA damage: formation, repair, and mutagenesis
-
PID: 12160927, COI: 1:CAS:528:DC%2BD38XlvVWmtbo%3D
-
Kasai H (2002) Chemistry-based studies on oxidative DNA damage: formation, repair, and mutagenesis. Free Radic Biol Med 33:450–456
-
(2002)
Free Radic Biol Med
, vol.33
, pp. 450-456
-
-
Kasai, H.1
-
85
-
-
33846703755
-
Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology
-
PID: 17234762, COI: 1:CAS:528:DC%2BD2sXmtVKlug%3D%3D
-
Kim YJ, Ahn JY, Liang P, Ip C, Zhang Y, Park YM (2007) Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res 67:546–554
-
(2007)
Cancer Res
, vol.67
, pp. 546-554
-
-
Kim, Y.J.1
Ahn, J.Y.2
Liang, P.3
Ip, C.4
Zhang, Y.5
Park, Y.M.6
-
86
-
-
0037971143
-
Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington’s disease
-
PID: 12807446, COI: 1:CAS:528:DC%2BD3sXltFelu7c%3D
-
Klivenyi P, Ferrante RJ, Gardian G, Browne S, Chabrier PE, Beal MF (2003) Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington’s disease. J Neurochem 86:267–272
-
(2003)
J Neurochem
, vol.86
, pp. 267-272
-
-
Klivenyi, P.1
Ferrante, R.J.2
Gardian, G.3
Browne, S.4
Chabrier, P.E.5
Beal, M.F.6
-
87
-
-
33745670171
-
Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis
-
PID: 16283096, COI: 1:CAS:528:DC%2BD28XnslSqt7s%3D
-
Koch M, Ramsaransing GS, Arutjunyan AV, Stepanov M, Teelken A, Heersema DJ, De Keyser J (2006) Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis. J Neurol 253:483–487
-
(2006)
J Neurol
, vol.253
, pp. 483-487
-
-
Koch, M.1
Ramsaransing, G.S.2
Arutjunyan, A.V.3
Stepanov, M.4
Teelken, A.5
Heersema, D.J.6
De Keyser, J.7
-
88
-
-
1542406446
-
NOX enzymes and the biology of reactive oxygen
-
PID: 15039755, COI: 1:CAS:528:DC%2BD2cXitlSnsbY%3D
-
Lambeth JD (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4:181–189
-
(2004)
Nat Rev Immunol
, vol.4
, pp. 181-189
-
-
Lambeth, J.D.1
-
89
-
-
0027422993
-
Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma
-
PID: 7689587, COI: 1:CAS:528:DyaK2cXhtVCmt7k%3D
-
Lee SC, Dickson DW, Liu W, Brosnan CF (1993) Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol 46:19–24
-
(1993)
J Neuroimmunol
, vol.46
, pp. 19-24
-
-
Lee, S.C.1
Dickson, D.W.2
Liu, W.3
Brosnan, C.F.4
-
90
-
-
0026755187
-
Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element
-
PID: 1340765, COI: 1:CAS:528:DyaK38XlsVClu78%3D
-
Li Y, Jaiswal AK (1992) Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. J Biol Chem 267:15097–15104
-
(1992)
J Biol Chem
, vol.267
, pp. 15097-15104
-
-
Li, Y.1
Jaiswal, A.K.2
-
91
-
-
35148835788
-
NF-E2 related factor 2 activation and heme oxygenase-1 induction by tert-butylhydroquinone protect against deltamethrin-mediated oxidative stress in PC12 cells
-
PID: 17676812, COI: 1:CAS:528:DC%2BD2sXos1Kkt7w%3D
-
Li HY, Zhong YF, Wu SY, Shi N (2007) NF-E2 related factor 2 activation and heme oxygenase-1 induction by tert-butylhydroquinone protect against deltamethrin-mediated oxidative stress in PC12 cells. Chem Res Toxicol 20:1242–1251
-
(2007)
Chem Res Toxicol
, vol.20
, pp. 1242-1251
-
-
Li, H.Y.1
Zhong, Y.F.2
Wu, S.Y.3
Shi, N.4
-
92
-
-
84886237017
-
Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice
-
PID: 24120440, COI: 1:CAS:528:DC%2BC3sXhvFWit7zI
-
Li B, Cui W, Liu J, Li R, Liu Q, Xie XH, Ge XL, Zhang J, Song XJ, Wang Y, Guo L (2013) Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice. Exp Neurol 250:239–249
-
(2013)
Exp Neurol
, vol.250
, pp. 239-249
-
-
Li, B.1
Cui, W.2
Liu, J.3
Li, R.4
Liu, Q.5
Xie, X.H.6
Ge, X.L.7
Zhang, J.8
Song, X.J.9
Wang, Y.10
Guo, L.11
-
93
-
-
33750347347
-
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
-
PID: 17051205, COI: 1:CAS:528:DC%2BD28XhtVyktbbO
-
Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787–795
-
(2006)
Nature
, vol.443
, pp. 787-795
-
-
Lin, M.T.1
Beal, M.F.2
-
94
-
-
79952136166
-
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
-
PID: 21354971
-
Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X, Buko A, Chollate S, Ellrichmann G, Bruck W, Dawson K, Goelz S, Wiese S, Scannevin RH, Lukashev M, Gold R (2011) Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134:678–692
-
(2011)
Brain
, vol.134
, pp. 678-692
-
-
Linker, R.A.1
Lee, D.H.2
Ryan, S.3
van Dam, A.M.4
Conrad, R.5
Bista, P.6
Zeng, W.7
Hronowsky, X.8
Buko, A.9
Chollate, S.10
Ellrichmann, G.11
Bruck, W.12
Dawson, K.13
Goelz, S.14
Wiese, S.15
Scannevin, R.H.16
Lukashev, M.17
Gold, R.18
-
95
-
-
0034965383
-
Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions
-
PID: 11395383, COI: 1:CAS:528:DC%2BD3MXkvFyksb0%3D
-
Liu JS, Zhao ML, Brosnan CF, Lee SC (2001) Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 158:2057–2066
-
(2001)
Am J Pathol
, vol.158
, pp. 2057-2066
-
-
Liu, J.S.1
Zhao, M.L.2
Brosnan, C.F.3
Lee, S.C.4
-
96
-
-
0034527964
-
NRH:quinone oxidoreductase2 (NQO2)
-
PID: 11154737, COI: 1:CAS:528:DC%2BD3MXitlOnug%3D%3D
-
Long DJ, Jaiswal AK (2000) NRH:quinone oxidoreductase2 (NQO2). Chem Biol Interact 129:99–112
-
(2000)
Chem Biol Interact
, vol.129
, pp. 99-112
-
-
Long, D.J.1
Jaiswal, A.K.2
-
97
-
-
84860835246
-
8OHdG as a marker for Huntington disease progression
-
PID: 22414782, COI: 1:CAS:528:DC%2BC38Xnt1ektro%3D
-
Long JD, Matson WR, Juhl AR, Leavitt BR, Paulsen JS (2012) 8OHdG as a marker for Huntington disease progression. Neurobiol Dis 46:625–634
-
(2012)
Neurobiol Dis
, vol.46
, pp. 625-634
-
-
Long, J.D.1
Matson, W.R.2
Juhl, A.R.3
Leavitt, B.R.4
Paulsen, J.S.5
-
98
-
-
0030714092
-
Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer’s disease
-
PID: 9390770, COI: 1:CAS:528:DyaK2sXns1OqsLY%3D
-
Lovell MA, Ehmann WD, Mattson MP, Markesbery WR (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer’s disease. Neurobiol Aging 18:457–461
-
(1997)
Neurobiol Aging
, vol.18
, pp. 457-461
-
-
Lovell, M.A.1
Ehmann, W.D.2
Mattson, M.P.3
Markesbery, W.R.4
-
99
-
-
0034662806
-
Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis
-
PID: 10980305, COI: 1:CAS:528:DC%2BD3cXmt1Sjt70%3D
-
Lu F, Selak M, O’Connor J, Croul S, Lorenzana C, Butunoi C, Kalman B (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 177:95–103
-
(2000)
J Neurol Sci
, vol.177
, pp. 95-103
-
-
Lu, F.1
Selak, M.2
O’Connor, J.3
Croul, S.4
Lorenzana, C.5
Butunoi, C.6
Kalman, B.7
-
100
-
-
66549118688
-
Mitochondrial changes within axons in multiple sclerosis
-
PID: 19293237
-
Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, Hanson PS, Lassmann H, Turnbull DM (2009) Mitochondrial changes within axons in multiple sclerosis. Brain 132:1161–1174
-
(2009)
Brain
, vol.132
, pp. 1161-1174
-
-
Mahad, D.J.1
Ziabreva, I.2
Campbell, G.3
Lax, N.4
White, K.5
Hanson, P.S.6
Lassmann, H.7
Turnbull, D.M.8
-
101
-
-
73949083799
-
NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington’s disease in rats: protective role of apocynin
-
PID: 19795371, COI: 1:CAS:528:DC%2BC3cXkvFGhsA%3D%3D
-
Maldonado PD, Molina-Jijon E, Villeda-Hernandez J, Galvan-Arzate S, Santamaria A, Pedraza-Chaverri J (2010) NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington’s disease in rats: protective role of apocynin. J Neurosci Res 88:620–629
-
(2010)
J Neurosci Res
, vol.88
, pp. 620-629
-
-
Maldonado, P.D.1
Molina-Jijon, E.2
Villeda-Hernandez, J.3
Galvan-Arzate, S.4
Santamaria, A.5
Pedraza-Chaverri, J.6
-
102
-
-
84885056536
-
MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis
-
PID: 24055980, COI: 1:CAS:528:DC%2BC3sXhslCrt7bE
-
Mao P, Manczak M, Shirendeb UP, Reddy PH (2013) MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Biochim Biophys Acta 1832:2322–2331
-
(2013)
Biochim Biophys Acta
, vol.1832
, pp. 2322-2331
-
-
Mao, P.1
Manczak, M.2
Shirendeb, U.P.3
Reddy, P.H.4
-
103
-
-
27644485874
-
Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview
-
PID: 16183338, COI: 1:CAS:528:DC%2BD2MXhtFOmsbnI
-
Mariani E, Polidori MC, Cherubini A, Mecocci P (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci 827:65–75
-
(2005)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.827
, pp. 65-75
-
-
Mariani, E.1
Polidori, M.C.2
Cherubini, A.3
Mecocci, P.4
-
104
-
-
35649018602
-
Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?
-
PID: 17956913
-
Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ (2007) Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 130:2800–2815
-
(2007)
Brain
, vol.130
, pp. 2800-2815
-
-
Marik, C.1
Felts, P.A.2
Bauer, J.3
Lassmann, H.4
Smith, K.J.5
-
105
-
-
0030915855
-
Oxidative stress hypothesis in Alzheimer’s disease
-
PID: 9165306, COI: 1:CAS:528:DyaK2sXjtlaqs7o%3D
-
Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med 23:134–147
-
(1997)
Free Radic Biol Med
, vol.23
, pp. 134-147
-
-
Markesbery, W.R.1
-
106
-
-
0006157248
-
Human copper-containing superoxide dismutase of high molecular weight
-
PID: 6961438, COI: 1:CAS:528:DyaL3sXkvFehug%3D%3D
-
Marklund SL (1982) Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci USA 79:7634–7638
-
(1982)
Proc Natl Acad Sci USA
, vol.79
, pp. 7634-7638
-
-
Marklund, S.L.1
-
107
-
-
84885020652
-
Glutathione peroxidase activity is neuroprotective in models of Huntington’s disease
-
PID: 23974869, COI: 1:CAS:528:DC%2BC3sXhtlWku7jP
-
Mason RP, Casu M, Butler N, Breda C, Campesan S, Clapp J, Green EW, Dhulkhed D, Kyriacou CP, Giorgini F (2013) Glutathione peroxidase activity is neuroprotective in models of Huntington’s disease. Nat Genet 45:1249–1254
-
(2013)
Nat Genet
, vol.45
, pp. 1249-1254
-
-
Mason, R.P.1
Casu, M.2
Butler, N.3
Breda, C.4
Campesan, S.5
Clapp, J.6
Green, E.W.7
Dhulkhed, D.8
Kyriacou, C.P.9
Giorgini, F.10
-
108
-
-
0016909223
-
Iron- and manganese-containing superoxide dismutases: structure, distribution, and evolutionary relationships
-
PID: 183482, COI: 1:CAS:528:DyaE1MXhs1eksLY%3D
-
McCord JM (1976) Iron- and manganese-containing superoxide dismutases: structure, distribution, and evolutionary relationships. Adv Exp Med Biol 74:540–550
-
(1976)
Adv Exp Med Biol
, vol.74
, pp. 540-550
-
-
McCord, J.M.1
-
109
-
-
18044363639
-
SOD, oxidative stress and human pathologies: a brief history and a future vision
-
PID: 15862706, COI: 1:CAS:528:DC%2BD2MXjs1Kmtrg%3D
-
McCord JM, Edeas MA (2005) SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomed Pharmacother 59:139–142
-
(2005)
Biomed Pharmacother
, vol.59
, pp. 139-142
-
-
McCord, J.M.1
Edeas, M.A.2
-
110
-
-
0014691242
-
Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)
-
PID: 5389100, COI: 1:CAS:528:DyaE3cXmsVU%3D
-
McCord JM, Fridovich I (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049–6055
-
(1969)
J Biol Chem
, vol.244
, pp. 6049-6055
-
-
McCord, J.M.1
Fridovich, I.2
-
111
-
-
0028152717
-
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
-
PID: 7979220, COI: 1:STN:280:DyaK2M%2FmvF2nsA%3D%3D
-
Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann Neurol 36:747–751
-
(1994)
Ann Neurol
, vol.36
, pp. 747-751
-
-
Mecocci, P.1
MacGarvey, U.2
Beal, M.F.3
-
112
-
-
0028061167
-
Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro
-
PID: 7969931, COI: 1:CAS:528:DyaK2cXlsFCktbw%3D
-
Mitrovic B, Ignarro LJ, Montestruque S, Smoll A, Merrill JE (1994) Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61:575–585
-
(1994)
Neuroscience
, vol.61
, pp. 575-585
-
-
Mitrovic, B.1
Ignarro, L.J.2
Montestruque, S.3
Smoll, A.4
Merrill, J.E.5
-
113
-
-
0036799799
-
Antioxidants as treatment for neurodegenerative disorders
-
PID: 12387703, COI: 1:CAS:528:DC%2BD38XosFGhsL4%3D
-
Moosmann B, Behl C (2002) Antioxidants as treatment for neurodegenerative disorders. Expert Opin Investig Drugs 11:1407–1435
-
(2002)
Expert Opin Investig Drugs
, vol.11
, pp. 1407-1435
-
-
Moosmann, B.1
Behl, C.2
-
114
-
-
0032970909
-
The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation
-
PID: 10065368, COI: 1:CAS:528:DyaK1MXhslCntrk%3D
-
Morrow JD, Chen Y, Brame CJ, Yang J, Sanchez SC, Xu J, Zackert WE, Awad JA, Roberts LJ (1999) The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. Drug Metab Rev 31:117–139
-
(1999)
Drug Metab Rev
, vol.31
, pp. 117-139
-
-
Morrow, J.D.1
Chen, Y.2
Brame, C.J.3
Yang, J.4
Sanchez, S.C.5
Xu, J.6
Zackert, W.E.7
Awad, J.A.8
Roberts, L.J.9
-
115
-
-
33845211714
-
Neuroinflammation, Oxidative Stress and the pathogenesis of Parkinson’s disease
-
PID: 18060039, COI: 1:CAS:528:DC%2BD28Xht12ksb3J
-
Mosley RL, Benner EJ, Kadiu I, Thomas M, Boska MD, Hasan K, Laurie C, Gendelman HE (2006) Neuroinflammation, Oxidative Stress and the pathogenesis of Parkinson’s disease. Clin Neurosci Res 6:261–281
-
(2006)
Clin Neurosci Res
, vol.6
, pp. 261-281
-
-
Mosley, R.L.1
Benner, E.J.2
Kadiu, I.3
Thomas, M.4
Boska, M.D.5
Hasan, K.6
Laurie, C.7
Gendelman, H.E.8
-
116
-
-
28844501852
-
Novel cytoprotective mechanism of anti-parkinsonian drug deprenyl: PI3K and Nrf2-derived induction of antioxidative proteins
-
PID: 16325767, COI: 1:CAS:528:DC%2BD2MXhtlajtLbM
-
Nakaso K, Nakamura C, Sato H, Imamura K, Takeshima T, Nakashima K (2006) Novel cytoprotective mechanism of anti-parkinsonian drug deprenyl: PI3K and Nrf2-derived induction of antioxidative proteins. Biochem Biophys Res Commun 339:915–922
-
(2006)
Biochem Biophys Res Commun
, vol.339
, pp. 915-922
-
-
Nakaso, K.1
Nakamura, C.2
Sato, H.3
Imamura, K.4
Takeshima, T.5
Nakashima, K.6
-
117
-
-
0037763721
-
Regulatory mechanisms controlling gene expression mediated by the antioxidant response element
-
PID: 12359864, COI: 1:CAS:528:DC%2BD3sXitFWqsbY%3D
-
Nguyen T, Sherratt PJ, Pickett CB (2003) Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 43:233–260
-
(2003)
Annu Rev Pharmacol Toxicol
, vol.43
, pp. 233-260
-
-
Nguyen, T.1
Sherratt, P.J.2
Pickett, C.B.3
-
118
-
-
3142570440
-
The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress
-
PID: 15256215, COI: 1:CAS:528:DC%2BD2cXlsl2nu7g%3D
-
Nguyen T, Yang CS, Pickett CB (2004) The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med 37:433–441
-
(2004)
Free Radic Biol Med
, vol.37
, pp. 433-441
-
-
Nguyen, T.1
Yang, C.S.2
Pickett, C.B.3
-
119
-
-
79953761792
-
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
-
PID: 21441916, COI: 1:CAS:528:DC%2BC3MXjvVOisrw%3D
-
Nikic I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, Bareyre FM, Bruck W, Bishop D, Misgeld T, Kerschensteiner M (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17:495–499
-
(2011)
Nat Med
, vol.17
, pp. 495-499
-
-
Nikic, I.1
Merkler, D.2
Sorbara, C.3
Brinkoetter, M.4
Kreutzfeldt, M.5
Bareyre, F.M.6
Bruck, W.7
Bishop, D.8
Misgeld, T.9
Kerschensteiner, M.10
-
120
-
-
33746868374
-
Oxidative damage to RNA in neurodegenerative diseases
-
PID: 17047315
-
Nunomura A, Honda K, Takeda A, Hirai K, Zhu X, Smith MA, Perry G (2006) Oxidative damage to RNA in neurodegenerative diseases. J Biomed Biotechnol 2006:82323
-
(2006)
J Biomed Biotechnol
, vol.2006
, pp. 82323
-
-
Nunomura, A.1
Honda, K.2
Takeda, A.3
Hirai, K.4
Zhu, X.5
Smith, M.A.6
Perry, G.7
-
121
-
-
84859759069
-
Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis
-
PID: 22355716
-
Pareek TK, Belkadi A, Kesavapany S, Zaremba A, Loh SL, Bai L, Cohen ML, Meyer C, Liby KT, Miller RH, Sporn MB, Letterio JJ (2011) Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis. Sci Rep 1:201
-
(2011)
Sci Rep
, vol.1
, pp. 201
-
-
Pareek, T.K.1
Belkadi, A.2
Kesavapany, S.3
Zaremba, A.4
Loh, S.L.5
Bai, L.6
Cohen, M.L.7
Meyer, C.8
Liby, K.T.9
Miller, R.H.10
Sporn, M.B.11
Letterio, J.J.12
-
122
-
-
41749104745
-
Complex I deficiency in Parkinson’s disease frontal cortex
-
PID: 18061150, COI: 1:CAS:528:DC%2BD1cXlt1CjtA%3D%3D
-
Parker WD Jr, Parks JK, Swerdlow RH (2008) Complex I deficiency in Parkinson’s disease frontal cortex. Brain Res 1189:215–218
-
(2008)
Brain Res
, vol.1189
, pp. 215-218
-
-
Parker, W.D.1
Parks, J.K.2
Swerdlow, R.H.3
-
123
-
-
12144288637
-
Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington’s disease mutation
-
PID: 15098934, COI: 1:CAS:528:DC%2BD2cXhvFWjsLk%3D
-
Perez-Severiano F, Santamaria A, Pedraza-Chaverri J, Medina-Campos ON, Rios C, Segovia J (2004) Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington’s disease mutation. Neurochem Res 29:729–733
-
(2004)
Neurochem Res
, vol.29
, pp. 729-733
-
-
Perez-Severiano, F.1
Santamaria, A.2
Pedraza-Chaverri, J.3
Medina-Campos, O.N.4
Rios, C.5
Segovia, J.6
-
124
-
-
84880392168
-
Study of oxidative damage and antioxidant systems in two Huntington’s disease rodent models
-
PID: 23754226, COI: 1:CAS:528:DC%2BC3sXhs1elsrnF
-
Perez-Severiano F, Montes S, Geronimo-Olvera C, Segovia J (2013) Study of oxidative damage and antioxidant systems in two Huntington’s disease rodent models. Methods Mol Biol 1010:177–200
-
(2013)
Methods Mol Biol
, vol.1010
, pp. 177-200
-
-
Perez-Severiano, F.1
Montes, S.2
Geronimo-Olvera, C.3
Segovia, J.4
-
125
-
-
17644413217
-
Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson’s disease
-
PID: 15890013, COI: 1:CAS:528:DC%2BD2MXktVWitrw%3D
-
Przedborski S, Ischiropoulos H (2005) Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson’s disease. Antioxid Redox Signal 7:685–693
-
(2005)
Antioxid Redox Signal
, vol.7
, pp. 685-693
-
-
Przedborski, S.1
Ischiropoulos, H.2
-
126
-
-
33846025116
-
Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis
-
PID: 16920708, COI: 1:CAS:528:DC%2BD28XhtVOrtrjO
-
Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J (2006) Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. J Biol Chem 281:31950–31962
-
(2006)
J Biol Chem
, vol.281
, pp. 31950-31962
-
-
Qi, X.1
Lewin, A.S.2
Sun, L.3
Hauswirth, W.W.4
Guy, J.5
-
127
-
-
33846073880
-
Expression of Nrf2 in neurodegenerative diseases
-
PID: 17204939, COI: 1:CAS:528:DC%2BD2sXhsV2qtb4%3D
-
Ramsey CP, Glass CA, Montgomery MB, Lindl KA, Ritson GP, Chia LA, Hamilton RL, Chu CT, Jordan-Sciutto KL (2007) Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol 66:75–85
-
(2007)
J Neuropathol Exp Neurol
, vol.66
, pp. 75-85
-
-
Ramsey, C.P.1
Glass, C.A.2
Montgomery, M.B.3
Lindl, K.A.4
Ritson, G.P.5
Chia, L.A.6
Hamilton, R.L.7
Chu, C.T.8
Jordan-Sciutto, K.L.9
-
128
-
-
19444375216
-
Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling
-
PID: 15917183, COI: 1:CAS:528:DC%2BD2MXks1WhurY%3D
-
Rhee SG, Chae HZ, Kim K (2005) Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38:1543–1552
-
(2005)
Free Radic Biol Med
, vol.38
, pp. 1543-1552
-
-
Rhee, S.G.1
Chae, H.Z.2
Kim, K.3
-
129
-
-
0032609801
-
P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson’s disease
-
PID: 10410732, COI: 1:CAS:528:DC%2BD3cXosVc%3D
-
Riedl AG, Watts PM, Brown CT, Jenner P (1999) P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson’s disease. Adv Neurol 80:271–286
-
(1999)
Adv Neurol
, vol.80
, pp. 271-286
-
-
Riedl, A.G.1
Watts, P.M.2
Brown, C.T.3
Jenner, P.4
-
130
-
-
33645945014
-
Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications
-
PID: 16601269, COI: 1:CAS:528:DC%2BD28Xktlylu7k%3D
-
Ryter SW, Alam J, Choi AM (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86:583–650
-
(2006)
Physiol Rev
, vol.86
, pp. 583-650
-
-
Ryter, S.W.1
Alam, J.2
Choi, A.M.3
-
131
-
-
33744950387
-
Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2
-
PID: 16551619, COI: 1:CAS:528:DC%2BD28XkslGqsbY%3D
-
Salazar M, Rojo AI, Velasco D, de Sagarra RM, Cuadrado A (2006) Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem 281:14841–14851
-
(2006)
J Biol Chem
, vol.281
, pp. 14841-14851
-
-
Salazar, M.1
Rojo, A.I.2
Velasco, D.3
de Sagarra, R.M.4
Cuadrado, A.5
-
132
-
-
0034915234
-
Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington’s disease
-
PID: 11495354, COI: 1:CAS:528:DC%2BD3MXlslSgtbg%3D
-
Santamaria A, Perez-Severiano F, Rodriguez-Martinez E, Maldonado PD, Pedraza-Chaverri J, Rios C, Segovia J (2001) Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington’s disease. Neurochem Res 26:419–424
-
(2001)
Neurochem Res
, vol.26
, pp. 419-424
-
-
Santamaria, A.1
Perez-Severiano, F.2
Rodriguez-Martinez, E.3
Maldonado, P.D.4
Pedraza-Chaverri, J.5
Rios, C.6
Segovia, J.7
-
133
-
-
84858648216
-
Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway
-
PID: 22267202, COI: 1:CAS:528:DC%2BC38XltVaguro%3D
-
Scannevin RH, Chollate S, Jung MY, Shackett M, Patel H, Bista P, Zeng W, Ryan S, Yamamoto M, Lukashev M, Rhodes KJ (2012) Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway. J Pharmacol Exp Ther 341:274–284
-
(2012)
J Pharmacol Exp Ther
, vol.341
, pp. 274-284
-
-
Scannevin, R.H.1
Chollate, S.2
Jung, M.Y.3
Shackett, M.4
Patel, H.5
Bista, P.6
Zeng, W.7
Ryan, S.8
Yamamoto, M.9
Lukashev, M.10
Rhodes, K.J.11
-
134
-
-
18544400323
-
Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo
-
PID: 9267034, COI: 1:CAS:528:DyaK2sXlsVKrsL4%3D
-
Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, Bates GP, Davies SW, Lehrach H, Wanker EE (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90:549–558
-
(1997)
Cell
, vol.90
, pp. 549-558
-
-
Scherzinger, E.1
Lurz, R.2
Turmaine, M.3
Mangiarini, L.4
Hollenbach, B.5
Hasenbank, R.6
Bates, G.P.7
Davies, S.W.8
Lehrach, H.9
Wanker, E.E.10
-
135
-
-
33745051595
-
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study
-
PID: 16796584, COI: 1:STN:280:DC%2BD28zotFagsw%3D%3D
-
Schimrigk S, Brune N, Hellwig K, Lukas C, Bellenberg B, Rieks M, Hoffmann V, Pohlau D, Przuntek H (2006) Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study. Eur J Neurol 13:604–610
-
(2006)
Eur J Neurol
, vol.13
, pp. 604-610
-
-
Schimrigk, S.1
Brune, N.2
Hellwig, K.3
Lukas, C.4
Bellenberg, B.5
Rieks, M.6
Hoffmann, V.7
Pohlau, D.8
Przuntek, H.9
-
136
-
-
8544257019
-
Heme oxygenase expression in human central nervous system disorders
-
PID: 15544918, COI: 1:CAS:528:DC%2BD2cXpslyju7c%3D
-
Schipper HM (2004) Heme oxygenase expression in human central nervous system disorders. Free Radic Biol Med 37:1995–2011
-
(2004)
Free Radic Biol Med
, vol.37
, pp. 1995-2011
-
-
Schipper, H.M.1
-
137
-
-
33746924887
-
Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity
-
PID: 16888025, COI: 1:CAS:528:DC%2BD28Xns1Kgs70%3D
-
Schreibelt G, Musters RJ, Reijerkerk A, de Groot LR, Van Der Pol SM, Hendrikx EM, Dopp ED, Dijkstra CD, Drukarch B, De Vries HE (2006) Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J Immunol 177:2630–2637
-
(2006)
J Immunol
, vol.177
, pp. 2630-2637
-
-
Schreibelt, G.1
Musters, R.J.2
Reijerkerk, A.3
de Groot, L.R.4
Van Der Pol, S.M.5
Hendrikx, E.M.6
Dopp, E.D.7
Dijkstra, C.D.8
Drukarch, B.9
De Vries, H.E.10
-
138
-
-
34347332411
-
The role of metals in the etiology of Alzheimer’s disease
-
PID: 17522444, COI: 1:CAS:528:DC%2BD2sXlsVCitLc%3D
-
Shcherbatykh I, Carpenter DO (2007) The role of metals in the etiology of Alzheimer’s disease. J Alzheimers Dis 11:191–205
-
(2007)
J Alzheimers Dis
, vol.11
, pp. 191-205
-
-
Shcherbatykh, I.1
Carpenter, D.O.2
-
139
-
-
20744440945
-
Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo
-
PID: 15840590, COI: 1:CAS:528:DC%2BD2MXltVyhtL8%3D
-
Shih AY, Imbeault S, Barakauskas V, Erb H, Jiang L, Li P, Murphy TH (2005a) Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J Biol Chem 280:22925–22936
-
(2005)
J Biol Chem
, vol.280
, pp. 22925-22936
-
-
Shih, A.Y.1
Imbeault, S.2
Barakauskas, V.3
Erb, H.4
Jiang, L.5
Li, P.6
Murphy, T.H.7
-
140
-
-
27744438478
-
A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo
-
PID: 16267240, COI: 1:CAS:528:DC%2BD2MXht1Wqt7%2FF
-
Shih AY, Li P, Murphy TH (2005b) A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J Neurosci 25:10321–10335
-
(2005)
J Neurosci
, vol.25
, pp. 10321-10335
-
-
Shih, A.Y.1
Li, P.2
Murphy, T.H.3
-
141
-
-
0034709603
-
Activation of NADPH oxidase in Alzheimer’s disease brains
-
PID: 10873554, COI: 1:CAS:528:DC%2BD3cXkt1Knurs%3D
-
Shimohama S, Tanino H, Kawakami N, Okamura N, Kodama H, Yamaguchi T, Hayakawa T, Nunomura A, Chiba S, Perry G, Smith MA, Fujimoto S (2000) Activation of NADPH oxidase in Alzheimer’s disease brains. Biochem Biophys Res Commun 273:5–9
-
(2000)
Biochem Biophys Res Commun
, vol.273
, pp. 5-9
-
-
Shimohama, S.1
Tanino, H.2
Kawakami, N.3
Okamura, N.4
Kodama, H.5
Yamaguchi, T.6
Hayakawa, T.7
Nunomura, A.8
Chiba, S.9
Perry, G.10
Smith, M.A.11
Fujimoto, S.12
-
142
-
-
84866395321
-
Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington’s disease
-
PID: 22709585, COI: 1:CAS:528:DC%2BC38XhtF2rurfI
-
Siddiqui A, Rivera-Sanchez S, Castro MR, cevedo-Torres K, Rane A, Torres-Ramos CA, Nicholls DG, Andersen JK, yala-Torres S (2012) Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington’s disease. Free Radic Biol Med 53:1478–1488
-
(2012)
Free Radic Biol Med
, vol.53
, pp. 1478-1488
-
-
Siddiqui, A.1
Rivera-Sanchez, S.2
Castro, M.R.3
cevedo-Torres, K.4
Rane, A.5
Torres-Ramos, C.A.6
Nicholls, D.G.7
Andersen, J.K.8
yala-Torres, S.9
-
143
-
-
0346386580
-
Widespread peroxynitrite-mediated damage in Alzheimer’s disease
-
PID: 9092586, COI: 1:CAS:528:DyaK2sXisValtL4%3D
-
Smith MA, Harris PLR, Sayre LM, Beckman JS, Perry G (1997) Widespread peroxynitrite-mediated damage in Alzheimer’s disease. J Neurosci 17:2653–2657
-
(1997)
J Neurosci
, vol.17
, pp. 2653-2657
-
-
Smith, M.A.1
Harris, P.L.R.2
Sayre, L.M.3
Beckman, J.S.4
Perry, G.5
-
144
-
-
0026644192
-
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson’s disease
-
PID: 1454205, COI: 1:CAS:528:DyaK38XmtFSju7w%3D
-
Sofic E, Lange KW, Jellinger K, Riederer P (1992) Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson’s disease. Neurosci Lett 142:128–130
-
(1992)
Neurosci Lett
, vol.142
, pp. 128-130
-
-
Sofic, E.1
Lange, K.W.2
Jellinger, K.3
Riederer, P.4
-
145
-
-
34248531658
-
Antioxidant capacity in postmortem brain tissues of Parkinson’s and Alzheimer’s diseases
-
Sofic E, Sapcanin A, Tahirovic I, Gavrankapetanovic I, Jellinger K, Reynolds GP, Tatschner T, Riederer P (2006) Antioxidant capacity in postmortem brain tissues of Parkinson’s and Alzheimer’s diseases. J Neural Transm Suppl 71:39-43
-
(2006)
J Neural Transm Suppl
, vol.71
, pp. 39-43
-
-
Sofic, E.1
Sapcanin, A.2
Tahirovic, I.3
Gavrankapetanovic, I.4
Jellinger, K.5
Reynolds, G.P.6
Tatschner, T.7
Riederer, P.8
-
146
-
-
0037111347
-
Comparison of uric acid and ascorbic acid in protection against EAE
-
PID: 12419468, COI: 1:CAS:528:DC%2BD38Xotl2mu7g%3D
-
Spitsin SV, Scott GS, Mikheeva T, Zborek A, Kean RB, Brimer CM, Koprowski H, Hooper DC (2002) Comparison of uric acid and ascorbic acid in protection against EAE. Free Radic Biol Med 33:1363–1371
-
(2002)
Free Radic Biol Med
, vol.33
, pp. 1363-1371
-
-
Spitsin, S.V.1
Scott, G.S.2
Mikheeva, T.3
Zborek, A.4
Kean, R.B.5
Brimer, C.M.6
Koprowski, H.7
Hooper, D.C.8
-
147
-
-
33749027475
-
Mechanisms and models of alpha-synuclein-related neurodegeneration
-
PID: 16928354, COI: 1:CAS:528:DC%2BD28XhtVOntr7F
-
Springer W, Kahle PJ (2006) Mechanisms and models of alpha-synuclein-related neurodegeneration. Curr Neurol Neurosci Rep 6:432–436
-
(2006)
Curr Neurol Neurosci Rep
, vol.6
, pp. 432-436
-
-
Springer, W.1
Kahle, P.J.2
-
148
-
-
77953537441
-
Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington’s disease
-
PID: 20338236, COI: 1:CAS:528:DC%2BC3cXntVOntrc%3D
-
Stack C, Ho D, Wille E, Calingasan NY, Williams C, Liby K, Sporn M, Dumont M, Beal MF (2010) Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington’s disease. Free Radic Biol Med 49:147–158
-
(2010)
Free Radic Biol Med
, vol.49
, pp. 147-158
-
-
Stack, C.1
Ho, D.2
Wille, E.3
Calingasan, N.Y.4
Williams, C.5
Liby, K.6
Sporn, M.7
Dumont, M.8
Beal, M.F.9
-
149
-
-
18144386929
-
Tryptophan metabolism and oxidative stress in patients with Huntington’s disease
-
PID: 15836620, COI: 1:CAS:528:DC%2BD2MXktFKgtbY%3D
-
Stoy N, Mackay GM, Forrest CM, Christofides J, Egerton M, Stone TW, Darlington LG (2005) Tryptophan metabolism and oxidative stress in patients with Huntington’s disease. J Neurochem 93:611–623
-
(2005)
J Neurochem
, vol.93
, pp. 611-623
-
-
Stoy, N.1
Mackay, G.M.2
Forrest, C.M.3
Christofides, J.4
Egerton, M.5
Stone, T.W.6
Darlington, L.G.7
-
150
-
-
33947644871
-
Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer’s disease: insights into mechanism of neurodegeneration from redox proteomics
-
PID: 17034347, COI: 1:CAS:528:DC%2BD28XhtVKntb%2FO
-
Sultana R, Perluigi M, Butterfield DA (2006) Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer’s disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid Redox Signal 8:2021–2037
-
(2006)
Antioxid Redox Signal
, vol.8
, pp. 2021-2037
-
-
Sultana, R.1
Perluigi, M.2
Butterfield, D.A.3
-
151
-
-
0029799756
-
Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress
-
PID: 8752107, COI: 1:CAS:528:DyaK28XltlKkt7k%3D
-
Thorburne SK, Juurlink BH (1996) Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J Neurochem 67:1014–1022
-
(1996)
J Neurochem
, vol.67
, pp. 1014-1022
-
-
Thorburne, S.K.1
Juurlink, B.H.2
-
152
-
-
34548620297
-
Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation
-
PID: 17623039, COI: 1:CAS:528:DC%2BD2sXhtF2qu7nM
-
Uversky VN (2007) Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. J Neurochem 103:17–37
-
(2007)
J Neurochem
, vol.103
, pp. 17-37
-
-
Uversky, V.N.1
-
153
-
-
84874536636
-
Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington’s disease
-
PID: 23223017, COI: 1:CAS:528:DC%2BC3sXivFKqt74%3D
-
Valencia A, Sapp E, Kimm JS, McClory H, Reeves PB, Alexander J, Ansong KA, Masso N, Frosch MP, Kegel KB, Li X, DiFiglia M (2013) Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington’s disease. Hum Mol Genet 22:1112–1131
-
(2013)
Hum Mol Genet
, vol.22
, pp. 1112-1131
-
-
Valencia, A.1
Sapp, E.2
Kimm, J.S.3
McClory, H.4
Reeves, P.B.5
Alexander, J.6
Ansong, K.A.7
Masso, N.8
Frosch, M.P.9
Kegel, K.B.10
Li, X.11
DiFiglia, M.12
-
154
-
-
2442668926
-
Hereditary early-onset Parkinson’s disease caused by mutations in PINK1
-
PID: 15087508, COI: 1:CAS:528:DC%2BD2cXktVyit7k%3D
-
Valente EM, bou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del TD, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary early-onset Parkinson’s disease caused by mutations in PINK1. Science 304:1158–1160
-
(2004)
Science
, vol.304
, pp. 1158-1160
-
-
Valente, E.M.1
bou-Sleiman, P.M.2
Caputo, V.3
Muqit, M.M.4
Harvey, K.5
Gispert, S.6
Ali, Z.7
Del, T.D.8
Bentivoglio, A.R.9
Healy, D.G.10
Albanese, A.11
Nussbaum, R.12
Gonzalez-Maldonado, R.13
Deller, T.14
Salvi, S.15
Cortelli, P.16
Gilks, W.P.17
Latchman, D.S.18
Harvey, R.J.19
Dallapiccola, B.20
Auburger, G.21
Wood, N.W.22
more..
-
155
-
-
0035430445
-
Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro
-
PID: 11481252
-
Van der Goes A, Wouters D, Van Der Pol SM, Huizinga R, Ronken E, Adamson P, Greenwood J, Dijkstra CD, De Vries HE (2001) Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro. FASEB J 15:1852–1854
-
(2001)
FASEB J
, vol.15
, pp. 1852-1854
-
-
Van der Goes, A.1
Wouters, D.2
Van Der Pol, S.M.3
Huizinga, R.4
Ronken, E.5
Adamson, P.6
Greenwood, J.7
Dijkstra, C.D.8
De Vries, H.E.9
-
156
-
-
56349160121
-
Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression
-
PID: 18930811
-
van Horssen J, Schreibelt G, Drexhage J, Hazes T, Dijkstra CD, Van der Valk P, De Vries HE (2008) Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic Biol Med 45:1729–1737
-
(2008)
Free Radic Biol Med
, vol.45
, pp. 1729-1737
-
-
van Horssen, J.1
Schreibelt, G.2
Drexhage, J.3
Hazes, T.4
Dijkstra, C.D.5
Van der Valk, P.6
De Vries, H.E.7
-
157
-
-
77956498372
-
Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions
-
PID: 20673799
-
van Horssen J, Drexhage JA, Flor T, Gerritsen W, Van der Valk P, De Vries HE (2010) Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radic Biol Med 49:1283–1289
-
(2010)
Free Radic Biol Med
, vol.49
, pp. 1283-1289
-
-
van Horssen, J.1
Drexhage, J.A.2
Flor, T.3
Gerritsen, W.4
Van der Valk, P.5
De Vries, H.E.6
-
159
-
-
0029971210
-
Amyloid beta protein primes cultured rat microglial cells for an enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity
-
PID: 8632171
-
Van Muiswinkel FL, Veerhuis R, Eikelenboom P (1996) Amyloid beta protein primes cultured rat microglial cells for an enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity. J Neurochem 66:2468–2476
-
(1996)
J Neurochem
, vol.66
, pp. 2468-2476
-
-
Van Muiswinkel, F.L.1
Veerhuis, R.2
Eikelenboom, P.3
-
160
-
-
0033118464
-
The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages
-
PID: 10227431
-
Van Muiswinkel FL, Raupp SF, de Vos NM, Smits HA, Verhoef J, Eikelenboom P, Nottet HS (1999) The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages. J Neuroimmunol 96:121–130
-
(1999)
J Neuroimmunol
, vol.96
, pp. 121-130
-
-
Van Muiswinkel, F.L.1
Raupp, S.F.2
de Vos, N.M.3
Smits, H.A.4
Verhoef, J.5
Eikelenboom, P.6
Nottet, H.S.7
-
161
-
-
4143150471
-
Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra
-
PID: 15312971
-
Van Muiswinkel FL, de Vos RA, Bol JG, Andringa G, Jansen Steur EN, Ross D, Siegel D, Drukarch B (2004) Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra. Neurobiol Aging 25:1253–1262
-
(2004)
Neurobiol Aging
, vol.25
, pp. 1253-1262
-
-
Van Muiswinkel, F.L.1
de Vos, R.A.2
Bol, J.G.3
Andringa, G.4
Jansen Steur, E.N.5
Ross, D.6
Siegel, D.7
Drukarch, B.8
-
162
-
-
33646103133
-
Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer’s disease
-
PID: 16483694
-
Volkel W, Sicilia T, Pahler A, Gsell W, Tatschner T, Jellinger K, Leblhuber F, Riederer P, Lutz WK, Gotz ME (2006) Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer’s disease. Neurochem Int 48:679–686
-
(2006)
Neurochem Int
, vol.48
, pp. 679-686
-
-
Volkel, W.1
Sicilia, T.2
Pahler, A.3
Gsell, W.4
Tatschner, T.5
Jellinger, K.6
Leblhuber, F.7
Riederer, P.8
Lutz, W.K.9
Gotz, M.E.10
-
163
-
-
77951176535
-
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson’s disease
-
von Otter M, Landgren S, Nilsson S, Celojevic D, Bergstrom P, Hakansson A, Nissbrandt H, Drozdzik M, Bialecka M, Kurzawski M, Blennow K, Nilsson M, Hammarsten O, Zetterberg H (2010a) Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson’s disease. BMC Med Genet 11:36
-
(2010)
BMC Med Genet
, vol.11
, pp. 36
-
-
von Otter, M.1
Landgren, S.2
Nilsson, S.3
Celojevic, D.4
Bergstrom, P.5
Hakansson, A.6
Nissbrandt, H.7
Drozdzik, M.8
Bialecka, M.9
Kurzawski, M.10
Blennow, K.11
Nilsson, M.12
Hammarsten, O.13
Zetterberg, H.14
-
164
-
-
77249083614
-
Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer’s disease and age-related cataract
-
von Otter M, Landgren S, Nilsson S, Zetterberg M, Celojevic D, Bergstrom P, Minthon L, Bogdanovic N, Andreasen N, Gustafson DR, Skoog I, Wallin A, Tasa G, Blennow K, Nilsson M, Hammarsten O, Zetterberg H (2010b) Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer’s disease and age-related cataract. Mech Ageing Dev 131:105–110
-
(2010)
Mech Ageing Dev
, vol.131
, pp. 105-110
-
-
von Otter, M.1
Landgren, S.2
Nilsson, S.3
Zetterberg, M.4
Celojevic, D.5
Bergstrom, P.6
Minthon, L.7
Bogdanovic, N.8
Andreasen, N.9
Gustafson, D.R.10
Skoog, I.11
Wallin, A.12
Tasa, G.13
Blennow, K.14
Nilsson, M.15
Hammarsten, O.16
Zetterberg, H.17
-
165
-
-
0041967387
-
Different faces of the heme–heme oxygenase system in inflammation
-
PID: 12869663, COI: 1:CAS:528:DC%2BD3sXnsVynurk%3D
-
Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, Figdor CG (2003) Different faces of the heme–heme oxygenase system in inflammation. Pharmacol Rev 55:551–571
-
(2003)
Pharmacol Rev
, vol.55
, pp. 551-571
-
-
Wagener, F.A.1
Volk, H.D.2
Willis, D.3
Abraham, N.G.4
Soares, M.P.5
Adema, G.J.6
Figdor, C.G.7
-
166
-
-
34147147998
-
Huntington’s Disease
-
PID: 17390259
-
Walker FO (2007) Huntington’s Disease. Semin Neurol 27:143–150
-
(2007)
Semin Neurol
, vol.27
, pp. 143-150
-
-
Walker, F.O.1
-
167
-
-
0031127418
-
Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques
-
PID: 9168828, COI: 1:CAS:528:DyaK2sXjtlOjtbY%3D
-
Wallace MN, Geddes JG, Farquhar DA, Masson MR (1997) Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques. Exp Neurol 144:266–272
-
(1997)
Exp Neurol
, vol.144
, pp. 266-272
-
-
Wallace, M.N.1
Geddes, J.G.2
Farquhar, D.A.3
Masson, M.R.4
-
168
-
-
82255173966
-
The unfolded protein response: from stress pathway to homeostatic regulation
-
PID: 22116877, COI: 1:CAS:528:DC%2BC3MXhsV2mu7jL
-
Walter P, Ron D (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334:1081–1086
-
(2011)
Science
, vol.334
, pp. 1081-1086
-
-
Walter, P.1
Ron, D.2
-
169
-
-
34547574317
-
Neuroprotective effects of free radical scavengers in stroke
-
PID: 17658905, COI: 1:CAS:528:DC%2BD2sXhtVeqtLnM
-
Wang CX, Shuaib A (2007) Neuroprotective effects of free radical scavengers in stroke. Drugs Aging 24:537–546
-
(2007)
Drugs Aging
, vol.24
, pp. 537-546
-
-
Wang, C.X.1
Shuaib, A.2
-
170
-
-
18844462415
-
Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer’s disease
-
PID: 15857398, COI: 1:CAS:528:DC%2BD2MXksFKgu7o%3D
-
Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA (2005) Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer’s disease. J Neurochem 93:953–962
-
(2005)
J Neurochem
, vol.93
, pp. 953-962
-
-
Wang, J.1
Xiong, S.2
Xie, C.3
Markesbery, W.R.4
Lovell, M.A.5
-
171
-
-
84868096374
-
Discovery of potent, novel Nrf2 inducers via quantum modeling, virtual screening, and in vitro experimental validation
-
PID: 22925725, COI: 1:CAS:528:DC%2BC38XhslCmu7bJ
-
Williamson TP, Amirahmadi S, Joshi G, Kaludov NK, Martinov MN, Johnson DA, Johnson JA (2012) Discovery of potent, novel Nrf2 inducers via quantum modeling, virtual screening, and in vitro experimental validation. Chem Biol Drug Des 80:810–820
-
(2012)
Chem Biol Drug Des
, vol.80
, pp. 810-820
-
-
Williamson, T.P.1
Amirahmadi, S.2
Joshi, G.3
Kaludov, N.K.4
Martinov, M.N.5
Johnson, D.A.6
Johnson, J.A.7
-
172
-
-
70349135156
-
Enhanced number and activity of mitochondria in multiple sclerosis lesions
-
PID: 19591199
-
Witte ME, Bo L, Rodenburg RJ, Belien JA, Musters R, Hazes T, Wintjes LT, Smeitink JA, Geurts JJ, De Vries HE, Van der Valk J, van Horssen J (2009) Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol 219:193–204
-
(2009)
J Pathol
, vol.219
, pp. 193-204
-
-
Witte, M.E.1
Bo, L.2
Rodenburg, R.J.3
Belien, J.A.4
Musters, R.5
Hazes, T.6
Wintjes, L.T.7
Smeitink, J.A.8
Geurts, J.J.9
De Vries, H.E.10
Van der Valk, J.11
van Horssen, J.12
-
173
-
-
77955385260
-
Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?
-
PID: 20573557, COI: 1:CAS:528:DC%2BC3cXpvFOnt7o%3D
-
Witte ME, Geurts JJ, De Vries HE, Van der Valk J, van Horssen J (2010) Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion 10:411–418
-
(2010)
Mitochondrion
, vol.10
, pp. 411-418
-
-
Witte, M.E.1
Geurts, J.J.2
De Vries, H.E.3
Van der Valk, J.4
van Horssen, J.5
-
174
-
-
38449086141
-
Luteolin protects rat PC12 and C6 cells against MPP + induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway
-
Wruck CJ, Claussen M, Fuhrmann G, Romer L, Schulz A, Pufe T, Waetzig V, Peipp M, Herdegen T, Gotz ME (2007) Luteolin protects rat PC12 and C6 cells against MPP + induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway. J Neural Transm Suppl 72:57-67
-
(2007)
J Neural Transm Suppl
, vol.72
, pp. 57-67
-
-
Wruck, C.J.1
Claussen, M.2
Fuhrmann, G.3
Romer, L.4
Schulz, A.5
Pufe, T.6
Waetzig, V.7
Peipp, M.8
Herdegen, T.9
Gotz, M.E.10
-
175
-
-
84884910504
-
Role of oxidative DNA damage in mitochondrial dysfunction and Huntington’s disease pathogenesis
-
yala-Pena S (2013) Role of oxidative DNA damage in mitochondrial dysfunction and Huntington’s disease pathogenesis. Free Radic Biol Med 62:102–110
-
(2013)
Free Radic Biol Med
, vol.62
, pp. 102-110
-
-
yala-Pena, S.1
-
176
-
-
33846315383
-
Increased 8-OHdG levels in the urine, serum, and substantia nigra of hemiparkinsonian rats
-
PID: 17188662, COI: 1:CAS:528:DC%2BD2sXpvV2ksg%3D%3D
-
Yasuhara T, Hara K, Sethi KD, Morgan JC, Borlongan CV (2007) Increased 8-OHdG levels in the urine, serum, and substantia nigra of hemiparkinsonian rats. Brain Res 1133:49–52
-
(2007)
Brain Res
, vol.1133
, pp. 49-52
-
-
Yasuhara, T.1
Hara, K.2
Sethi, K.D.3
Morgan, J.C.4
Borlongan, C.V.5
-
177
-
-
0029917194
-
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease
-
PID: 8610103, COI: 1:CAS:528:DyaK28XitVCis7Y%3D
-
Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 93:2696–2701
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 2696-2701
-
-
Yoritaka, A.1
Hattori, N.2
Uchida, K.3
Tanaka, M.4
Stadtman, E.R.5
Mizuno, Y.6
-
178
-
-
29244479186
-
Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents
-
PID: 16233958, COI: 1:CAS:528:DC%2BD2MXhtlGitrnK
-
Zhao J, Kobori N, Aronowski J, Dash PK (2006) Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett 393:108–112
-
(2006)
Neurosci Lett
, vol.393
, pp. 108-112
-
-
Zhao, J.1
Kobori, N.2
Aronowski, J.3
Dash, P.K.4
-
179
-
-
34548850603
-
Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury
-
PID: 17881530, COI: 1:CAS:528:DC%2BD2sXhtFahsbfE
-
Zhao J, Moore AN, Redell JB, Dash PK (2007) Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J Neurosci 27:10240–10248
-
(2007)
J Neurosci
, vol.27
, pp. 10240-10248
-
-
Zhao, J.1
Moore, A.N.2
Redell, J.B.3
Dash, P.K.4
|